23 March 2023: ReNeuron Group plc (AIM: RENE), a UK-based R&D organisation focused on exosome delivery technologies, announces the appointment of Allenby Capital Limited as the Company’s Nominated Adviser and Sole Broker, with immediate effect.

Read more…

Back